A61K 39/245
Herpetoviridae
Official title: Herpetoviridae, e.g. herpes simplex virus
A61K39/245 (Herpetoviridae) appears on 843 US grants and 1,084 published applications in this corpus.
Search patents in A61K- Granted patents
- 843
- Published applications
- 1,084
- Assignees
- 514
- Inventors
- 1,909
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 5 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 8 | 0 |
| 1992 | 11 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 17 | 0 |
| 1998 | 38 | 0 |
| 1999 | 23 | 0 |
| 2000 | 20 | 0 |
| 2001 | 23 | 6 |
| 2002 | 23 | 26 |
| 2003 | 16 | 23 |
| 2004 | 14 | 38 |
| 2005 | 10 | 24 |
| 2006 | 9 | 16 |
| 2007 | 11 | 23 |
| 2008 | 14 | 25 |
| 2009 | 14 | 25 |
| 2010 | 12 | 32 |
| 2011 | 16 | 38 |
| 2012 | 15 | 32 |
| 2013 | 20 | 48 |
| 2014 | 29 | 52 |
| 2015 | 25 | 55 |
| 2016 | 30 | 48 |
| 2017 | 43 | 55 |
| 2018 | 41 | 50 |
| 2019 | 56 | 57 |
| 2020 | 39 | 61 |
| 2021 | 40 | 58 |
| 2022 | 39 | 59 |
| 2023 | 25 | 74 |
| 2024 | 31 | 59 |
| 2025 | 37 | 49 |
| 2026 | 23 | 51 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Vaccines, vaccine priming, and antigen dose sparing22 Sep 2026US 12,741,022 B2Adjuvance Technologies, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Modified mRNA vaccines encoding herpes simplex virus glycoproteins and uses thereof11 Aug 2026US 12,702,707 B2The Trustees of the University of Pennsylvania
- Treatment using oncolytic virus21 Jul 2026US 12,685,767 B2Replimune Limited
- Varicella zoster7 Jul 2026US 12,673,101 B2Adjuvance Technologies, Inc.
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Natural attenuated strain of infectious laryngotracheitis virus with good safety and good immunogenicity and use thereof8 Oct 2026US 2026/0306619 A1Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences
- Nucleic acid-lipid nanoparticle composition, and lyophilized preparation thereof, preparation method therefor and use thereof1 Oct 2026US 2026/0294829 A1Cansino Biologics Inc.
- Compositions of mrna-encoded virus-like particles, compositions of mrna-lipid nanoparticles, and methods for use thereof1 Oct 2026US 2026/0295033 A1
- Mutated fragment of vzv glycoprotein e1 Oct 2026US 2026/0295035 A1
Most cited
By later US patents
- Human cytomegalovirus RNA vaccines130US 10,064,935 B2ModernaTX, Inc. · 2018
- Microemulsions with adsorbed macromolecules and microparticles125US 8,734,832 B2Novartis AG · 2014
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Hybrid particle immunogens118US 4,722,840 AChiron Corporation · 1988
- Microparticles with adsorbent surfaces, methods of making same, and uses thereof95US 6,884,435 B1Chiron Corporation · 2005